The News: With the evidence increasingly weighing in against amyloid beta as the best solo target for Alzheimer’s, startup Cortexyme Inc. (South San Francisco) has identified a brand-new target and… Read more »
The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »
Background: Alzinova AB (Gothenburg) is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease (AD). The company was founded in 2011… Read more »